Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity

This publication has 55 references indexed in Scilit:

• The Non-cyclooxygenase Targets of Non-steroidal Anti-inflammatory Drugs, Lipoxygenases, Peroxisome Proliferator-activated Receptor, Inhibitor of κB Kinase, and NFκB, Do Not Reduce Amyloid β42 Production
  Journal of Biological Chemistry, 2003
• An inflammatory drug prospect
  Nature, 2001
• Biochemical Characterization of the γ-Secretase Activity That Produces β-Amyloid Peptides
  Biochemistry, 2001
• FAD Mutations in Presenilin-1 or Amyloid Precursor Protein Decrease the Efficacy of a γ-Secretase Inhibitor: Evidence for Direct Involvement of PS1 in the γ-Secretase Cleavage Complex
  Neurobiology of Disease, 2000
• Cell‐free assays for γ‐secretase activity
  The FASEB Journal, 2000
• Difluoro Ketone Peptidomimetics Suggest a Large S1 Pocket for Alzheimer's γ-Secretase: Implications for Inhibitor Design
  Journal of Medicinal Chemistry, 2000
• Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer’s disease
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
• Improved electrophoretic separation and immunoblotting of beta‐amyloid (Aβ) peptides 1–40, 1–42, and 1–43
  Electrophoresis, 1997
• Enhanced Release of Amyloid -Protein from Codon 670/671 Swedish Mutant -Amyloid Precursor Protein Occurs in Both Secretory and Endocytic Pathways
  Journal of Biological Chemistry, 1996
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
  Neuron, 1994